Stock listing
NASDAQ:ONCR Oncorus Inc Stock
Follow Oncorus Inc into a list and get an email when it puts out news.
Delisted NASDAQ:ONCR no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:ONCR
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
Oncorus Inc on 6ix
- Decks
- 1 deck · latest Jan 10, 2022
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Investor Presentation (January 2022) | Investor deck | 24 slides | Jan 10, 2022 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Briggs Morrison Other companies: CRISPR Therapeutics AG (Director · Since at least Jun 5, 2025); Werewolf Therapeutics, Inc. (Director · Since at least Apr 29, 2021); Arvinas, Inc. (Chair of the Arvinas Board of Directors · Since at least Sep 26, 2018); Carisma Therapeutics, Inc. (Director · Mar 7, 2023 – Jun 26, 2024 · Past); Codiak BioSciences Inc (Director · Oct 13, 2020 – Feb 17, 2021 · Past); Repare Therapeutics Inc (Director · Jun 18, 2020 – Jun 17, 2024 · Past); NextCure, Inc. (Director · May 8, 2019 – Jun 11, 2020 · Past); Syndax Pharmaceuticals, Inc. (Director · Mar 2, 2016 – Feb 7, 2024 · Past) | Director · Oct 1, 2020 – Oct 1, 2020 · Past |
| Scott A Canute Other companies: Flexion Therapeutics Inc (Director · Jun 20, 2018 – Nov 19, 2021 · Past); Akebia Therapeutics, Inc. (Director · Jun 14, 2018 – Jun 6, 2019 · Past); Protara Therapeutics, Inc. (Director · Jun 8, 2018 – Jun 8, 2018 · Past); Immunomedics Inc (Director · Apr 2, 2018 – Oct 23, 2020 · Past); Outlook Therapeutics, Inc. (Director · Oct 26, 2017 – Oct 26, 2017 · Past) | Director · Dec 11, 2020 – Jun 23, 2022 · Past |
| Mary Kay Fenton Other companies: Cullinan Therapeutics, Inc. (Chief Financial Officer · Since at least Apr 29, 2024); Tourmaline Bio Inc. (Chief Financial Officer · May 6, 2021 – Jul 3, 2023 · Past); Achillion Pharmaceuticals Inc (Chief Financial Officer · Dec 12, 2011 – Feb 9, 2018 · Past) | Director · Oct 1, 2020 – Jun 23, 2022 · Past |
| Douglas Fambrough Other companies: Dicerna Pharmaceuticals Inc (Chief Executive Officer, Director · Aug 10, 2021 – Dec 28, 2021 · Past) | Director · Jun 22, 2022 – Jun 22, 2022 · Past |
| Rick Wanstall Other companies: Rein Therapeutics, Inc. (See Remarks · Mar 27, 2019 – Mar 30, 2022 · Past) | CFO and Treasurer · May 10, 2022 – May 25, 2022 · Past |
| Theodore Ashburn Other companies: Dicerna Pharmaceuticals Inc (See Remarks · Dec 15, 2014 – Jan 8, 2016 · Past) | President and CEO, Director · Oct 1, 2020 – Mar 1, 2022 · Past |
| Brian J Shea | Interim CEO · Jun 6, 2023 – Jun 6, 2023 · Past |
| Christophe Queva | CSO and SVP, Research · Oct 1, 2020 – Mar 1, 2022 · Past |
| John Mayer Goldberg | Chief Medical Officer · Oct 1, 2020 – Mar 1, 2022 · Past |
Log in to ask 6ix AI your own questions about Oncorus Inc.